U.S. Government Cuts Funding and Contracts for Moderna's Bird Flu Vaccine Development
The US Department of Health and Human Services canceled a $590 million contract with Moderna for developing H5 avian flu vaccines, raising concerns among health experts about preparedness for potential bird flu pandemics, despite Moderna's positive clinical trial results and the company's plans to explore alternative development options.